Divalent Ion Metabolism and Renal Osteodystrophy
Publisher
Springer Netherlands
Reference20 articles.
1. Barragry JM, France MW, Carter ND, et al: Vitamin-D metabolism in nephrotic syndrome. Lancet 2: 629–632, 1977. 2. Brewer ED, Tsai H, Morris RC Jr, et al: Fanconi syndrome and its relationship to vitamin D in Vitamin D Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism (Norman AW, Schaefer R, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG and Herrath DV, eds), de Gruyter, Berlin, p 937, 1977. 3. Chesney RW, Mazess RB, Hamstra AJ, et al: Reduction of serum-1,25- dihydroxy-vitamin-D3 in children receiving glucocorticoids. Lancet 2:1123–1125, 1978. 4. Chesney RW, Moorthy AV, Eisman JA, et al: Increased growth after long-term oral 1,25-vitamin D3 in childhood renal osteodystrophy. New Eng J Med 298: 238–242, 1978. 5. Christiansen C, Rodbro P, Christiansen MS, et al: Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydrdxycholecalciferol. Lancet 2: 700–703, 1978.
|
|